Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, We are informed by our Registrar, regarding issuance of duplicate share certificate, as detailed in enclosed letter. Request you to take note of the same. Thanking You. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrar and Transfer Agent, Kfin Technologies Limited on October 19,2023 regarding loss/misplacement of share certificate(s) as detailed in enclosed letter. Please take note of the same. Procter & Gamble Health Ltd - 500126 - 56Th Annual General Meeting And Payment Of Dividend
We would like to inform you that the 56th Annual General Meeting( AGM) of the Company is to be held on Thursday, November 30,2023. The register of members and share transfer books shall remain closed from Friday, November 24,2023 to Thursday, November 30,2023 for the purpose of the AGM and payment of dividend for the year ended June 30,2023. Procter & Gamble Health Ltd - 500126 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
On basis of confirmation received from our RTA, we hereby submit certificate as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, We have been updated by our RTA about loss of share certificate, as detailed in attached letter, as detailed in enclosed letter. Request you to kindly take note of the same. Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for Directors and Designated employees from October 1, 2023 until 48 hours from publication of the unaudited financial results for quarter ended September 30, 2023. Procter & Gamble Health Ltd - 500126 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On November 3, 2023
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 ,inter alia, to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 3, 2023, inter alia, to consider and approve the Unaudited Financial Results for the Quarter ended September 30, 2023. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Find enclosed details with respect to loss of share certificate(s) of the shareholder(s) of the Company. Kindly take the same on record. Procter & Gamble Health Ltd - 500126 - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Dear Sir, Pursuant to provisions of Regulation 30 and other applicable provisions, if any, of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Company plans to source injections portfolio of its products from a contract manufacturer, hence the Company shall discontinue production of injections at its manufacturing plant at Goa effective September 30, 2023. The Company is outsourcing manufacturing of the injections portfolio , with an intent to achieve cost efficiency and supply optimization. Said discontinuation of production at Company''s plant in Goa, shall not have an impact on continuity of sale of injections by the Company. Further details are mentioned in attached letter. Request you to kindly take note of the same and oblige. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Find enclosed details with respect to loss of share certificates(s) received from shareholder(s) of the Company.